[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"detail-sidebar-cat-0-en-105":3,"doc-seo-345390-105":59,"doc-detail-345390-en":130},{"code":4,"msg":5,"data":6},0,"success",[7,13,18,23,28,33,38,43,48,51,55],{"id":8,"doc_module":4,"doc_module_name":9,"category_name":10,"show_sort_weight":11,"slug":12},1,"Document","Story & Novel",90,"story-novel",{"id":14,"doc_module":4,"doc_module_name":9,"category_name":15,"show_sort_weight":16,"slug":17},2,"Literature",80,"literature",{"id":19,"doc_module":4,"doc_module_name":9,"category_name":20,"show_sort_weight":21,"slug":22},4,"Exam",70,"exam",{"id":24,"doc_module":4,"doc_module_name":9,"category_name":25,"show_sort_weight":26,"slug":27},5,"Comic",60,"comic",{"id":29,"doc_module":4,"doc_module_name":9,"category_name":30,"show_sort_weight":31,"slug":32},6,"Technology",50,"technology",{"id":34,"doc_module":4,"doc_module_name":9,"category_name":35,"show_sort_weight":36,"slug":37},7,"Healthcare",40,"healthcare",{"id":39,"doc_module":4,"doc_module_name":9,"category_name":40,"show_sort_weight":41,"slug":42},8,"Research & Report",30,"research-report",{"id":44,"doc_module":4,"doc_module_name":9,"category_name":45,"show_sort_weight":46,"slug":47},9,"Religion & Spirituality",20,"religion-spirituality",{"id":46,"doc_module":4,"doc_module_name":9,"category_name":49,"show_sort_weight":46,"slug":50},"World Cup","world-cup",{"id":52,"doc_module":4,"doc_module_name":9,"category_name":53,"show_sort_weight":52,"slug":54},10,"Lifestyle","lifestyle",{"id":56,"doc_module":4,"doc_module_name":9,"category_name":57,"show_sort_weight":24,"slug":58},19,"General","general",{"code":4,"msg":60,"data":61},"ok",{"site_id":62,"language":63,"slug":64,"title":65,"keywords":66,"description":67,"schema_data":68,"social_meta":123,"head_meta":125,"extra_data":127,"updated_unix":129},105,"en","integrated-transcriptomic-and-metabolomic-analyses-reveal-targeting-hexokinase-2-disrupts-glycolysis-and-nucleotide-metabolism-to-inhibit-nsclc-growth","Integrated transcriptomic and metabolomic analyses reveal targeting hexokinase 2 disrupts glycolysis and nucleotide metabolism to inhibit NSCLC growth","","Background Dysregulated glycolysis is a hallmark of non-small cell lung cancer (NSCLC), and hexokinase 2 (HK2) is implicated in tumor energy homeostasis. Methods integrated transcriptomic and metabolomic analyses assessed TCGA correlations among HK isoforms for prognosis and used siRNA to knock down HK2 in NCI-H1975 cells. Results HK2 was linked to poor outcomes; depletion reduced HK1/HK2, suppressed proliferation, shifted the cell cycle toward G0/G1, and impaired nucleotide metabolism via the pentose phosphate pathway. Conclusion Targeting HK2 disrupts NSCLC growth by coordinating nucleotide metabolism under impaired glycolysis.",{"@graph":69,"@context":122},[70,84,105],{"@type":71,"itemListElement":72},"BreadcrumbList",[73,77,79,82],{"item":74,"name":75,"@type":76,"position":8},"https://docshare.wps.com","Home","ListItem",{"item":78,"name":9,"@type":76,"position":14},"https://docshare.wps.com/document/",{"item":80,"name":40,"@type":76,"position":81},"https://docshare.wps.com/document/research-report/",3,{"item":83,"name":65,"@type":76,"position":19},"https://docshare.wps.com/document/integrated-transcriptomic-and-metabolomic-analyses-reveal-targeting-hexokinase-2-disrupts-glycolysis-and-nucleotide-metabolism-to-inhibit-nsclc-growth/345390/",{"url":83,"name":65,"@type":85,"image":86,"author":91,"headline":65,"publisher":94,"fileFormat":97,"inLanguage":63,"description":67,"dateModified":98,"datePublished":99,"encodingFormat":97,"isAccessibleForFree":100,"interactionStatistic":101},"DigitalDocument",{"url":87,"@type":88,"width":89,"height":90},"https://docshare.wps.com/thumbnails/integrated-transcriptomic-and-metabolomic-analyses-reveal-targeting-hexokinase-2-disrupts-glycolysis-and-nucleotide-metabolism-to-inhibit-nsclc-growth/345390.png","ImageObject",300,407,{"name":92,"@type":93},"Ezra","Person",{"url":74,"name":95,"@type":96},"DocShare","Organization","application/pdf","2026-11-03","2026-09-22",true,{"@type":102,"interactionType":103,"userInteractionCount":52},"InteractionCounter",{"@type":104},"ViewAction",{"@type":106,"mainEntity":107},"FAQPage",[108,114,118],{"name":109,"@type":110,"acceptedAnswer":111},"What role does HK2 play in NSCLC metabolism according to the study?","Question",{"text":112,"@type":113},"The study frames HK2 as a key driver of metabolic reprogramming in NSCLC, particularly supporting energy homeostasis via glycolysis-related pathways.","Answer",{"name":115,"@type":110,"acceptedAnswer":116},"How did the researchers test the effect of HK2 in NSCLC cells?",{"text":117,"@type":113},"They used siRNA-mediated HK2 knockdown in NCI-H1975 cells and evaluated proliferation, cell cycle progression, and apoptosis with assays including CCK-8, EdU incorporation, and flow cytometry.",{"name":119,"@type":110,"acceptedAnswer":120},"Which metabolic pathway was most affected by HK2 depletion?",{"text":121,"@type":113},"Integrated omics analyses showed disrupted nucleotide metabolism, with specific impairment of the pentose phosphate pathway (PPP), which supports ribonucleotide synthesis.","https://schema.org",{"og:url":83,"og:type":124,"og:title":65,"og:site_name":95,"og:description":67},"article",{"robots":126,"canonical":83},"index,follow",{"doc_id":128,"site_id":62},345390,1790161888,{"code":4,"msg":5,"data":131},{"doc_id":128,"user_id":132,"nickname":92,"user_avatar":133,"doc_module":4,"category_id":39,"category_name":40,"doc_title":65,"doc_description":67,"doc_content":134,"file_id":135,"file_url":136,"file_type":137,"file_size":138,"view_count":52,"is_deleted":4,"is_public":8,"is_downloadable":8,"audit_status":8,"page_count":139,"language":140,"language_code":63,"site_id":62,"html_lang":63,"table_of_contents":141,"faqs":142,"seo_title":143,"seo_description":67,"update_tm":144,"read_time":145,"preview_page_count":19,"preview_urls":146},1099514068035,"https://ap-avatar.wpscdn.com/davatar_276721f389ce27ea32af1340a28f341c","Zhou et al. World Journal of Surgical Oncology (2026) 24:207  \n[https://doi.org/10.1186/s12957-026-04334-2](https://doi.org/10.1186/s12957-026-04334-2)  \nWorld Journal of Surgical Oncology  \nRESEARCH Open Access  \nIntegrated transcriptomic and metabolomic  analyses reveal targeting hexokinase 2  \ndisrupts glycolysis and nucleotide metabolism to inhibit NSCLC growth  \nJuan Zhou1†, Rudan Deng2,3†, Linyun Pan2,3†, Qingqing Zhao2, Yan Wang2, Qun Wang3, Yong Liu2 and Yang Yu2,4*  \nAbstract  \nBackground Dysregulation of glycolysis is a hallmark of non-small cell lung cancer (NSCLC), with hexokinases (HKs) playing a critical role in cancer metabolism. Among them, HK2 is particularly involved in tumor energy homeostasis and has emerged as a potential therapeutic target. This study explores the impact of HK2 targeting on NSCLC cell growth and metabolism through a comprehensive analysis of transcriptomic and metabolomic data.  \nMethods Data from The Cancer Genome Atlas (TCGA) were used to examine the correlation between the expression of different HK isoforms (HK1, HK2, HK3) and patient prognosis in NSCLC. siRNA-mediated knockdown of HK2 was performed in NCI-H1975 cells, which exhibit relatively high HK2 expression based on CCLE datasets. The effects on cell proliferation, cell cycle progression, and apoptosis were evaluated using CCK-8 assays, EdU incorporation, and flow cytometry. Integrated transcriptomic and metabolomic analyses were conducted to identify key metabolic pathways influencing cell growth and progression.  \nResults Elevated expression of HK2 in NSCLC was associated with poor prognosis. Knockdown of HK2 led to a significant reduction in both HK1 and HK2 levels, resulting in decreased cell proliferation and a marked shift in the cell cycle to the G0/G1 phase. Integrated omics analyses revealed that HK2 depletion disrupted nucleotide metabolism, specifically impairing the pentose phosphate pathway (PPP), which is vital for ribonucleotide synthesis.  \nConclusion Targeting HK2 disrupts NSCLC cell growth and cell cycle progression by modulating nucleotide metabolism under conditions of inhibited glycolysis, highlighting its potential as a therapeutic target in cancer metabolism.  \nKeywords Hexokinase 2 (HK2), Non-small cell lung cancer (NSCLC), Cell growth, Cell cycle, Glycolysis, Nucleotide metabolism  \n†Juan Zhou, Rudan Deng and Linyun Pan contributed equally to this work.  \n*Correspondence:  \nYang Yu [403627437@njmu.edu.cn](403627437@njmu.edu.cn)  \n1Department of Clinical Laboratory, Xuzhou Clinical School of Xuzhou Medical University & Xuzhou Central Hospital, Xuzhou, China 2Department of Medical Oncology, Xuzhou Clinical School of Xuzhou Medical University & Xuzhou Central Hospital, Xuzhou, China 3Graduate School of Xuzhou Medical College, Xuzhou, China 4Oncology Department, Xuzhou Central Hospital, Southeast University, Xuzhou, China  \n© The Author(s) 2026. Open Access This article is licensed under a Creative Commons Attribution-NonCommercial-NoDerivatives 4.0 International License, which permits any non-commercial use, sharing, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if you modified the licensed material. You do not have permission under this licence to share adapted material derived from this article or parts of it. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit [http://creati](http://creati)[vecommons.org/licenses/by-nc-nd/4.0/](vecommons.org/licenses/by-nc-nd/4.0/.)[.](","cbCaiif1Kgx9s244","https://ap.wps.com/l/cbCaiif1Kgx9s244","pdf",7403640,14,"English","# Abstract\n# Background\n# Methods\n## TCGA correlation analysis\n## HK2 knockdown experiments\n# Results\n# Conclusion","[{\"question\":\"What role does HK2 play in NSCLC metabolism according to the study?\",\"answer\":\"The study frames HK2 as a key driver of metabolic reprogramming in NSCLC, particularly supporting energy homeostasis via glycolysis-related pathways.\"},{\"question\":\"How did the researchers test the effect of HK2 in NSCLC cells?\",\"answer\":\"They used siRNA-mediated HK2 knockdown in NCI-H1975 cells and evaluated proliferation, cell cycle progression, and apoptosis with assays including CCK-8, EdU incorporation, and flow cytometry.\"},{\"question\":\"Which metabolic pathway was most affected by HK2 depletion?\",\"answer\":\"Integrated omics analyses showed disrupted nucleotide metabolism, with specific impairment of the pentose phosphate pathway (PPP), which supports ribonucleotide synthesis.\"}]","Integrated transcriptomic and metabolomic analyses reveal targeting hexokinase 2 disrupts glycolysis and nucleotide metabolism to inhibit NSCLC growth | PDF",1790057507,35,[147,151,155,159],{"page_no":8,"url":148,"width":149,"height":150},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/ff9de35f552d2a4a6e772603f528c7fe.webp",983,1310,{"page_no":14,"url":152,"width":153,"height":154},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/e8de0991f6c5d2cd4e6e74011abb5bf4.webp",982,1309,{"page_no":81,"url":156,"width":157,"height":158},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/3fddf6c4df8f05ead73d3169da35b76d.webp",981,1308,{"page_no":19,"url":160,"width":161,"height":162},"https://res-academy.cache.wpscdn.com/upload/kdocshare/2026-11-16/f34886ef11d29d6f838ecad1139e355b.webp",980,1306]